149 related articles for article (PubMed ID: 38126217)
21. Salivary interleukin-1β as a biomarker to differentiate between periodontal health, gingivitis, and periodontitis.
Abdullameer MA; Abdulkareem AA
Minerva Dent Oral Sci; 2023 Oct; 72(5):221-229. PubMed ID: 37162330
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of Serum Leucine-Rich Alpha-2 Glycoprotein as a New Inflammatory Biomarker of Inflammatory Bowel Disease.
Yoshimura T; Mitsuyama K; Sakemi R; Takedatsu H; Yoshioka S; Kuwaki K; Mori A; Fukunaga S; Araki T; Morita M; Tsuruta K; Yamasaki H; Torimura T
Mediators Inflamm; 2021; 2021():8825374. PubMed ID: 33623482
[TBL] [Abstract][Full Text] [Related]
23. The potentiality of salivary peptide biomarkers for screening patients with periodontal diseases by mass spectrometry.
Tang H; Yuan C; Ma Z; Zhu C; Tong P; Gallagher JE; Sun X; Zheng S
Clin Chim Acta; 2019 Aug; 495():278-286. PubMed ID: 31026423
[TBL] [Abstract][Full Text] [Related]
24. Salivary Outer Membrane Vesicles and DNA Methylation of Small Extracellular Vesicles as Biomarkers for Periodontal Status: A Pilot Study.
Han P; Bartold PM; Salomon C; Ivanovski S
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33670900
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of salivary biomarkers for the diagnosis of periodontitis.
Zhang Y; Kang N; Xue F; Qiao J; Duan J; Chen F; Cai Y
BMC Oral Health; 2021 May; 21(1):266. PubMed ID: 34001101
[TBL] [Abstract][Full Text] [Related]
26. Six miRNA expressions in the saliva of smokers and non-smokers with periodontal disease.
Öngöz Dede F; Gökmenoğlu C; Türkmen E; Bozkurt Doğan Ş; Ayhan BS; Yildirim K
J Periodontal Res; 2023 Feb; 58(1):195-203. PubMed ID: 36495003
[TBL] [Abstract][Full Text] [Related]
27. Serum leucine-rich α2 glycoprotein as a potential biomarker for systemic inflammation in Parkinson's disease.
Ohmichi T; Kasai T; Shinomoto M; Kitani-Morii F; Fujino Y; Menjo K; Mizuno T
PLoS One; 2023; 18(2):e0282153. PubMed ID: 36812242
[TBL] [Abstract][Full Text] [Related]
28. ELISA for human serum leucine-rich alpha-2-glycoprotein-1 employing cytochrome c as the capturing ligand.
Weivoda S; Andersen JD; Skogen A; Schlievert PM; Fontana D; Schacker T; Tuite P; Dubinsky JM; Jemmerson R
J Immunol Methods; 2008 Jul; 336(1):22-9. PubMed ID: 18436231
[TBL] [Abstract][Full Text] [Related]
29. Global metabolomic analysis of human saliva and plasma from healthy and diabetic subjects, with and without periodontal disease.
Barnes VM; Kennedy AD; Panagakos F; Devizio W; Trivedi HM; Jönsson T; Guo L; Cervi S; Scannapieco FA
PLoS One; 2014; 9(8):e105181. PubMed ID: 25133529
[TBL] [Abstract][Full Text] [Related]
30. Local and systemic levels of aMMP-8 in gingivitis and stage 3 grade C periodontitis.
Keles Yucel ZP; Afacan B; Emingil G; Tervahartiala T; Kose T; Sorsa T
J Periodontal Res; 2020 Dec; 55(6):887-894. PubMed ID: 32790178
[TBL] [Abstract][Full Text] [Related]
31. Salivary levels of alpha 2-macroglobulin, alpha 1-antitrypsin, C-reactive protein, cathepsin G and elastase in humans with or without destructive periodontal disease.
Pederson ED; Stanke SR; Whitener SJ; Sebastiani PT; Lamberts BL; Turner DW
Arch Oral Biol; 1995 Dec; 40(12):1151-5. PubMed ID: 8850655
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the salivary levels of visfatin, chemerin, and progranulin in periodontal inflammation.
Özcan E; Saygun NI; Serdar MA; Kurt N
Clin Oral Investig; 2015 May; 19(4):921-8. PubMed ID: 25164155
[TBL] [Abstract][Full Text] [Related]
33. Salivary infectious agents and periodontal disease status.
Saygun I; Nizam N; Keskiner I; Bal V; Kubar A; Açıkel C; Serdar M; Slots J
J Periodontal Res; 2011 Apr; 46(2):235-9. PubMed ID: 21261620
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of galectin-3, peptidylarginine deiminase-4, and tumor necrosis factor-α levels in gingival crevicular fluid for periodontal health, gingivitis, and Stage III Grade C periodontitis: A pilot study.
Akkaya HÜ; Yılmaz HE; Narin F; Sağlam M
J Periodontol; 2022 Jan; 93(1):80-88. PubMed ID: 33913157
[TBL] [Abstract][Full Text] [Related]
35. Effect of periodontal therapy on serum C-reactive protein levels in patients with gingivitis and chronic periodontitis: a clinicobiochemical study.
Patil VA; Desai MH
J Contemp Dent Pract; 2013 Mar; 14(2):233-7. PubMed ID: 23811651
[TBL] [Abstract][Full Text] [Related]
36. Salivary and serum procalcitonin and C-reactive protein as biomarkers of periodontitis in United States veterans with osteoarthritis or rheumatoid arthritis.
Redman RS; Kerr GS; Payne JB; Mikuls TR; Huang J; Sayles HR; Becker KL; Nylén ES
Biotech Histochem; 2016; 91(2):77-85. PubMed ID: 26800284
[TBL] [Abstract][Full Text] [Related]
37. Salivary Del-1, IL-17, and LFA-1 levels in periodontal health and disease.
Inönü E; Kayis SA; Eskan MA; Hakki SS
J Periodontal Res; 2020 Aug; 55(4):511-518. PubMed ID: 32153040
[TBL] [Abstract][Full Text] [Related]
38. Salivary E-cadherin as a biomarker for diagnosis and predicting grade of periodontitis.
Kazem NM; Abdulkareem AA; Milward MR
J Periodontal Res; 2023 Aug; 58(4):715-722. PubMed ID: 37186464
[TBL] [Abstract][Full Text] [Related]
39. Gingival crevicular fluid galectin-3 and interleukin-1 beta levels in stage 3 periodontitis with grade B and C.
Afacan B; Ilhan HA; Köse T; Emingil G
Clin Oral Investig; 2023 Jul; 27(7):3749-3758. PubMed ID: 37017753
[TBL] [Abstract][Full Text] [Related]
40. Changes in salivary biomarkers associated with periodontitis and diabetic neuropathy in individuals with type 1 diabetes.
Steigmann L; Maekawa S; Kauffmann F; Reiss J; Cornett A; Sugai J; Venegas J; Fan X; Xie Y; Giannobile WV; Pop-Busui R; Lombaert IMA
Sci Rep; 2022 Jul; 12(1):11284. PubMed ID: 35788667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
